PREPAYMENTS AND OTHER CURRENT ASSETS (Tables)

12 Months Ended

Dec. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepayments and Other Current Assets

Prepayments and other current assets consist of the following:

			As at December 31,
	Notes		2017			2018			2018
			RMB			RMB			US$
Due from suppliers		i)		23,243			10,751			1,564
Due from hospitals		ii)		1,179			576			84
Loan receivables		iii)		114,456			151,139			21,982
Advances to employees		iv)		4,383			1,056			154
Receivables from disposal of medical equipment		v)		90,324			69,410			10,096
Deferred expenses				111			50			7
Interest receivable				5,100			3,680			535
Dividend receivable				766			766			111
Others				29,959			5,084			739
				269,521			242,512			35,272

Reserve for unrecoverable deposits				(4,798	)		(14,798	)		(2,152	)

				264,723			227,714			33,120

Provisions are recorded in “general and administrative expenses” in the consolidated statements of comprehensive loss.

Amounts due from suppliers represent prepayments made for orders and returnable deposits of cancelled orders. The risk of loss arising from non-performance by or bankruptcy of suppliers is assessed prior to the order of the equipment. The Group has provided reserve amounting to RMB4,798 and RMB4,798 (US$698) on amounts due from suppliers as at December 31, 2017 and 2018, respectively.

ii)

Amounts due from hospitals represent interest-free advances to hospitals and the compensation to be received from hospitals for early termination. The Group has assessed the impact of such advances on revenue recognition at the outset of the arrangement and has concluded that they do not affect revenue recognition. The risk of loss arising from any failure of hospital customers to fulfill their financial obligations is assessed prior to making the advances and is monitored for recoverability on a regular basis by management.

iii)

Loan receivables represented the loans to other parties, including loans to related parties such as the Xi’an JiangyuanAndike Ltd. (“JYADK”), Beijing Allcure Medical Information Technology Co., Ltd. (“Allcure Information”), Shanghai Meizhongjiahe Imaging Diagnostic Center Co. Ltd. (“SH MJZH”) and Wuxi Meizhongjiahe Cancer Centre(“Wuxi MZJH”) of total amount of

RMB13,658 and RMB15,118 (US$2,199)

as at December 31, 2017 and 2018, and third parties of RMB85,798 and RMB136,021(US$

19,783

) as at December 31, 2017 and 2018, respectively, which is an interest free loan balance. The Group has provided reserve amounting to nil and RMB10,000 (US$1,454) on third parties as at December 31, 2017 and 2018, respectively. Besides, the loan to JYADK contributed to interest receivable of

RMB221 and RMB454(US$66)

as at December 31, 2017 and 2018, respectively (note 24).

iv)

The advances to employees represent interest-free advance held by the Company’s employees to cover expenses of hospital customers. The risk of loss is assessed prior to making the advances and is monitored on a regular basis by management. Historically, the Group has not experienced any loss of such advances.

Receivables from disposal of medical equipment represented the consideration to be received from several hospitals, which the Group entered into termination contracts with and disposed all leasing equipment to.